Clinical trial
Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
NCT00005077 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00005077 |
|---|---|
| Title | Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction |
| Official title | Phase I Study of Oxaliplatin in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction (Summary Last Modified 04/2000) |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Start date | Feb 1, 2000 |
| First posted | Apr 12, 2004 |
| Last update posted | Jan 6, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: